Status:
COMPLETED
Chronic Obstructive Pulmonary Disease and Pulmonary Hypertension: Prevalence and Quality of Life
Lead Sponsor:
Wissenschaftliches Institut Bethanien e.V
Collaborating Sponsors:
Actelion Pharmaceuticals Deutschland GmbH
Conditions:
Hypertension, Pulmonary
Pulmonary Disease, Chronic Obstructive
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to determine the prevalence of pulmonary hypertension (PH) among patients suffering from Chronic Obstructive Pulmonary Disease (COPD) and to assess the quality of life in ...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Known or newly diagnosed COPD or PAH
- Written informed consent
- Present long-term oxygen treatment is no exclusion criterion
Exclusion
- Age \< 18 years
- Right-heart catheterization not reasonable
- Pregnancy, Lactation
- Life expectancy \<12 months due to any diseases aside from COPD
- Any medical, psychological or other condition, which limits the patient's ability to provide informed consent
- No written informed consent provided
- Current participation in another clinical trial
Key Trial Info
Start Date :
August 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2015
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT01423071
Start Date
August 1 2011
End Date
January 1 2015
Last Update
June 18 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bethanien Hospital, Clinic for Pneumology and Allergology, Center for Sleep Medicine and Respiratory Care, Institute for Pneumology at the University Witten/Herdecke
Solingen, North Rhine-Westphalia, Germany, 42699